475,000 Shares in Medline $MDLN Bought by Alberta Investment Management Corp

Alberta Investment Management Corp acquired a new position in shares of Medline (NASDAQ:MDLN) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 475,000 shares of the company’s stock, valued at approximately $19,950,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sound Income Strategies LLC acquired a new position in shares of Medline in the fourth quarter worth $25,000. Entrust Financial LLC acquired a new position in shares of Medline in the fourth quarter worth $26,000. NBC Securities Inc. purchased a new stake in shares of Medline in the fourth quarter valued at $28,000. Global Retirement Partners LLC purchased a new stake in shares of Medline in the fourth quarter valued at $31,000. Finally, North Star Investment Management Corp. purchased a new stake in shares of Medline in the fourth quarter valued at $36,000.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on MDLN shares. Weiss Ratings downgraded Medline from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. BMO Capital Markets lifted their price objective on Medline from $45.00 to $54.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Deutsche Bank Aktiengesellschaft set a $42.00 price objective on Medline in a research report on Thursday, May 7th. UBS Group lifted their price objective on Medline from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Finally, Stifel Nicolaus set a $55.00 target price on Medline in a research report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $50.54.

Insider Buying and Selling at Medline

In related news, insider Jessi L. Corcoran bought 5,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $34.15 per share, with a total value of $170,750.00. Following the completion of the transaction, the insider directly owned 5,000 shares of the company’s stock, valued at approximately $170,750. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.81% of the stock is owned by insiders.

Medline Price Performance

Shares of NASDAQ:MDLN opened at $37.33 on Tuesday. The firm has a market capitalization of $49.04 billion and a price-to-earnings ratio of 116.66. The company has a debt-to-equity ratio of 0.65, a current ratio of 4.41 and a quick ratio of 2.51. The stock’s 50-day moving average price is $40.62. Medline has a 12 month low of $32.81 and a 12 month high of $50.88.

Medline (NASDAQ:MDLN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.29 by $0.04. The firm had revenue of $7.35 billion for the quarter. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. As a group, research analysts anticipate that Medline will post 1.51 earnings per share for the current year.

Medline Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.